you are here: Home News Covaxin

Covaxin

Bharat Biotech adds ICMR as co-owner of Covaxin patent
‘Incorrect, Misleading’: ICMR Seeks Retraction Of BHU Study On Covaxin Side Effects, Warns Of Legal Action
ICMR discredits BHU study on Covaxin safety for methodological flaws
Over 30% of Covaxin recipients report 'adverse events' in BHU study. What are the side effects?
Ocugen-Bharat Biotech COVID vaccine meets main goals in US trial
Bharat Biotech’s Covaxin inching closer to US launch plan?
Covishield immune responses against Covid variants higher than Covaxin: Study
Govt rubbishes reports on approval for Covaxin due to political pressure
50 million doses of Covaxin set to expire early 2023 due to poor off take
Can Bharat Biotech's intranasal vaccine prevent COVID-19 infection and transmission?
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
Covaxin booster doses effective against variants, shows study
Political will at the top and community participation at the bottom drove India's COVID-19 vaccination campaign: Dr N K Arora
Moneycontrol Selects: Top stories this evening
NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years
COVID-19 shots administered in India about to overtake count in all of Europe, North America
Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech
Covaxin more effective for kids and adolescents than adults, Bharat Biotech publishes trial data
We are able to predict pandemic based on changes in virus, other signals: Bharat Biotech founder
Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study
Paraguay cancels order for one million Covaxin doses citing quality issues: Reports
Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin
Germany to recognise Bharat Biotech’s Covaxin for travel from June 1
FDA lifts hold on Covaxin's clinical trials in US
Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Covaxin

Bharat Biotech adds ICMR as co-owner of Covaxin patent

‘Incorrect, Misleading’: ICMR Seeks Retraction Of BHU Study On Covaxin Side Effects, Warns Of Legal Action

ICMR discredits BHU study on Covaxin safety for methodological flaws

Over 30% of Covaxin recipients report 'adverse events' in BHU study. What are the side effects?

Ocugen-Bharat Biotech COVID vaccine meets main goals in US trial

Bharat Biotech’s Covaxin inching closer to US launch plan?

Covishield immune responses against Covid variants higher than Covaxin: Study

Govt rubbishes reports on approval for Covaxin due to political pressure

50 million doses of Covaxin set to expire early 2023 due to poor off take

Can Bharat Biotech's intranasal vaccine prevent COVID-19 infection and transmission?

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Covaxin booster doses effective against variants, shows study

Political will at the top and community participation at the bottom drove India's COVID-19 vaccination campaign: Dr N K Arora

Moneycontrol Selects: Top stories this evening

NTAGI's technical sub-committee recommends use of Corbevax, Covaxin for children between 5-12 years

COVID-19 shots administered in India about to overtake count in all of Europe, North America

Covaxin proven safe for children of 2-18 years age group in phase III study: Bharat Biotech

Covaxin more effective for kids and adolescents than adults, Bharat Biotech publishes trial data

We are able to predict pandemic based on changes in virus, other signals: Bharat Biotech founder

Covaxin booster dose enhances vaccine effectiveness against Delta, Omicron variants, says ICMR study

Paraguay cancels order for one million Covaxin doses citing quality issues: Reports

Top virologists weigh in for Corbevax booster after primary vaccination with Covishield, Covaxin

Germany to recognise Bharat Biotech’s Covaxin for travel from June 1

FDA lifts hold on Covaxin's clinical trials in US

Covid-19: 10 crore doses of SII's Covovax approved for exports by govt lab, stock rolled out for teens